{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:39:28Z","timestamp":1792492768241,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015627","name":"Quest Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["SI-2103-37386"],"award-info":[{"award-number":["SI-2103-37386"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.msard.2026.107975","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:28:24Z","timestamp":1791646104000},"page":"107975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal humoral and cellular immune responses to COVID-19 vaccination in persons with multiple sclerosis across disease-modifying therapy classes"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1359","authenticated-orcid":false,"given":"Farren B.S.","family":"Briggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-8341","authenticated-orcid":false,"given":"Stephanie","family":"Buxhoeveden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce F.","family":"Bebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0854-3996","authenticated-orcid":false,"given":"Phyllis","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-1004","authenticated-orcid":false,"given":"Robert N.","family":"McBurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-4694","authenticated-orcid":false,"given":"Michael K.","family":"Racke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1060-8960","authenticated-orcid":false,"given":"Sara","family":"Loud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107975_bib0001","article-title":"Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies","volume":"14","author":"Achiron","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107975_bib0002","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","volume":"27","author":"Apostolidis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2026.107975_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168102","article-title":"Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination","volume":"8","author":"Asashima","year":"2023","journal-title":"JCI. Insight."},{"key":"10.1016\/j.msard.2026.107975_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41541-023-00794-9","article-title":"A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation","volume":"9","author":"Binayke","year":"2024","journal-title":"NPJ. Vaccines."},{"key":"10.1016\/j.msard.2026.107975_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001104","article-title":"COVID-19 vaccination reactogenicity in persons with multiple sclerosis","volume":"9","author":"Briggs","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107975_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106253","article-title":"Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosis","volume":"94","author":"Briggs","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107975_bib0007","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41541-025-01151-8","article-title":"Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy","volume":"10","author":"Davis-Porada","year":"2025","journal-title":"NPJ. Vaccines."},{"key":"10.1016\/j.msard.2026.107975_bib0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cei\/uxad027","article-title":"Evaluation of QuantiFERON SARS-CoV-2 interferon-gamma release assay following SARS-CoV-2 infection and vaccination","volume":"212","author":"Johnson","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2026.107975_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(21)00394-5","article-title":"Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study","volume":"4","author":"Jyssum","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.msard.2026.107975_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106947","article-title":"Real-world COVID-19 immunity in multiple sclerosis (CoVaR-MS): a longitudinal follow up study","volume":"107","author":"Kalra","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107975_bib0011","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2026.107975_bib0012","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bjh.17877","article-title":"T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies","volume":"196","author":"Marasco","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.msard.2026.107975_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200393","article-title":"SARS-CoV-2 vaccines and Multiple sclerosis: an update","volume":"12","author":"Monschein","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107975_bib0014","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/annrheumdis-2021-220781","article-title":"SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity","volume":"80","author":"Mrak","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2026.107975_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1432348","article-title":"Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort study","volume":"15","author":"Novak","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107975_bib0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2021.01.003","article-title":"Advances in gene-based vaccine platforms to address the COVID-19 pandemic","volume":"170","author":"Pushparajah","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msard.2026.107975_bib0017","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156978","article-title":"Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function","volume":"7","author":"Sabatino","year":"2022","journal-title":"JCI. Insight."},{"key":"10.1016\/j.msard.2026.107975_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00107-6","article-title":"Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial","volume":"4","author":"Seekircher","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.msard.2026.107975_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103581","article-title":"Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies","volume":"72","author":"Sormani","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.msard.2026.107975_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11497","article-title":"Factors associated with serological response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with Rituximab","volume":"5","author":"Tolf","year":"2022","journal-title":"JAMa Netw. Open."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:52:58Z","timestamp":1792489978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826010102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"alternative-id":["S2211034826010102"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107975","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal humoral and cellular immune responses to COVID-19 vaccination in persons with multiple sclerosis across disease-modifying therapy classes","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107975"}}